Teva Pharmaceuticals is trading 4.5% down at ILA 10,380 as investors lock in profits following a significant rally last week.
- The stock recently surged after reporting upbeat earnings and raising its 2026 revenue guidance.
- Today's move appears to be driven by normal market volatility and profit-taking, with no fresh company-specific news reported.